Olian Judy D.
SEC Form 4 insider trading activity
Olian Judy D. has filed 9 SEC Form 4 filings (9 transaction rows) across 3 companies, including ARES, UTHR, MAT, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Aug 4, 2026.
On the most recent filing, Olian Judy D. is listed as Director at UNITED THERAPEUTICS Corp. Inside the rolling window, Olian Judy D. reported 1 open-market purchase totaling $60K in ARES and 5 open-market sales totaling $1.2M in UTHR. The largest disclosed transaction in the window is a sale of 1,800 UTHR shares on Sep 19, 2025, worth $748K.
Companies traded
Other insiders at ARES
Insider Buying
$60K
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Olian Judy D. made?
Olian Judy D. has filed 9 SEC Form 4 filings (9 transaction rows) across 3 companies, including ARES, UTHR, MAT since 2025.
Which companies does Olian Judy D. trade?
Olian Judy D. has filed SEC Form 4 disclosures for 3 companies, including ARES, UTHR, MAT.
When was Olian Judy D.'s most recent SEC Form 4 filing?
Olian Judy D.'s most recent SEC Form 4 filing on Tracefour is dated Aug 4, 2026.
What is Olian Judy D.'s total buy and sell value in the current window?
Inside the rolling retention window, Olian Judy D. bought $60K and sold $1.2M based on SEC Form 4 filings.
What was Olian Judy D.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,800 UTHR shares on 2025-09-19, worth $748K, per SEC Form 4 filings.